Renal Cell Carcinoma — Trials

Renal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,621 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 375
Recruiting: 193
Ph III recruiting: 14
Growth YoY: +1.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (276)

clinicaltrialsPublishedShowing 601–650 of 681 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00891475	Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients	completed	Phase 1 / Phase 2	114	Kidney Cancer Research BureauOTHER	1	Feb 13, 2014	clinicaltrials
NCT00523640	A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma	terminated	Phase 2	30	University of ChicagoOTHER	1	Feb 11, 2014	clinicaltrials